![Yann Echelard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 12 M $ in data 30/06/2026
Dr. Yann Echelard is a Founding President at Ampersand Biomedicines, Inc., an Operating Partner at Flagship Pioneering, Inc. and an Independent Director at TG Therapeutics, Inc. He is on the Board of Directors at TG Therapeutics, Inc., Hema Biologics and LFB USA, Inc. Dr. Echelard was previously employed as a President by Profound Therapeutics, Inc., a President, Chief Executive Officer & Director by rEVO Biologics, Inc., a Founding President by Cellarity Inc., a President by Laronde, Inc., and a Founding President by Ring Therapeutics, Inc. He also served on the board at GTC Biotherapeutics UK Ltd. He received his doctorate degree from the University of Montréal.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 223.816 ( 0,15% ) | 12 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TG THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 09/11/2012 |
Hema Biologics
 Hema Biologics Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | - |
LFB USA, Inc.
 LFB USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicinal products | Direttore/Membro del Consiglio | - |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Investitore di Private Equity | 01/10/2018 |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Fondatore | 01/01/2021 |
| Società | Posizione | Fine |
|---|---|---|
| REVO BIOLOGICS INC | Amministratore Delegato | 01/04/2018 |
GTC Biotherapeutics UK Ltd. | Direttore/Membro del Consiglio | 01/12/2010 |
Profound Therapeutics
 Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Fondatore | - |
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Fondatore | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
LFB USA, Inc.
LFB USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicinal products | Health Technology |
GTC Biotherapeutics UK Ltd. | |
Hema Biologics
Hema Biologics Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Cellarity Inc.
 Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Laronde Inc.
Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Commercial Services |
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Health Technology |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
